IONIX PHARMACEUTICALS
Ionix Pharmaceuticals, based in Cambridge UK, is a leader in the discovery and development of new analgesic medicines for the treatment of acute and chronic pain. Using proprietary drug targets and state-of-the-art chemistry, the company is developing medicines that are designed to alleviate pain associated with trauma, operative procedures, and debilitating diseases such as arthritis, diabetes and multiple sclerosis. Ionix Pharmaceuticals is a privately held company and was founded in 2001.
IONIX PHARMACEUTICALS
Industry:
Health Care Medical Pharmaceutical
Founded:
2001-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Total Employee:
101+
Status:
Active
Total Funding:
27.2 M USD
Similar Organizations
Aprea
Aprea is a biopharmaceutical company that develops novel cancer therapeutics.
Aptarion biotech
Aptarion biotech is a developer Biostable L-Aptamers for the treatment Of Life-Threatening diseases And for Biosensors.
Curadis GmbH
Curadis GmbH provides researches and develops steroidal medicines for breast cancer and benign enlargement.
Ennar Pharma
Development of medicines for the treatment of psoriasis.
Pharmion
Pharmion engages in the acquisition, development, and commercialization of products for the treatment of hematology and oncology patients.
Investors List
Wellcome Trust
Wellcome Trust investment in Series B - Ionix Pharmaceuticals
Apax Partners
Apax Partners investment in Series B - Ionix Pharmaceuticals
More informations about "Ionix Pharmaceuticals"
Ionix Pharmaceuticals - Company Profile - Tracxn
Oct 23, 2024 Ionix Pharmaceuticals company profile. Developer of analgesic medicines for the acute and chronic pain. 2001 • Cambridge (United Kingdom) • Acquired • Cambridge (United …See details»
Ionix Pharmaceuticals - Funding, Financials, Valuation & Investors
Organization. Ionix Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 2. ... Series B - …See details»
Ionix Pharmaceuticals - Products, Competitors, Financials, …
Ionix Pharmaceuticals was founded in 2001. Where is Ionix Pharmaceuticals's headquarters? Ionix Pharmaceuticals's headquarters is located at Unit 418 Cambridge Science Park, …See details»
Ionix Pharmaceuticals Ltd. - Drug pipelines, Patents ... - Patsnap
Explore Ionix Pharmaceuticals Ltd. with its drug pipeline, therapeutic area, technology platform, 4 literature, Drug:IP-05.See details»
Ionix Pharmaceuticals Ltd.: Drug pipelines, Patents, Clinical trials ...
Jun 14, 2023 Explore Ionix Pharmaceuticals Ltd. with its drug pipeline, therapeutic area, technology platform, 1 news, and 6 literature.See details»
Ionix Pharmaceuticals - Crunchbase
A leader in the discovery and development of new analgesic medicines for the treatment of acute and chronic pain.See details»
Ionix Pharmaceuticals - VentureRadar
Ionix Pharmaceuticals VentureRadar profile. Find out more about Ionix Pharmaceuticals including the VentureRadar Innovation and Growth scores, Similar Companies and more. ... Ardena …See details»
Ionix Pharmaceuticals Ltd. - Scrip
Jul 1, 2002 Ionix, which was created around IP relating to the discovery of ion channel targets for pain therapeutics, is balancing the risks of discovering novel drugs with programs based on …See details»
Ionix Pharmaceuticals Ltd. - BioCentury Company Profiles - BCIQ
Ionix Pharmaceuticals Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
Ionix Pharmaceuticals Ltd. | Insights
Jul 16, 2010 Pharmaceuticals; See more in Biomedtracker. Latest on Ionix Pharmaceuticals Ltd. Already A Biomedtracker Subscriber? You have access to the full company record through …See details»
Ionix Pharmaceuticals Stock Price, Funding, Valuation, Revenue ...
See Ionix Pharmaceuticals funding rounds, investors, investments, exits and more. Evaluate their financials based on Ionix Pharmaceuticals's post-money valuation and revenue. Ionix …See details»
Vernalis Growing Through £12.5M Ionix Acquisition - | BioWorld
Jul 7, 2005 LONDON - Vernalis plc is acquiring Ionix Pharmaceuticals Ltd. in an all-share deal that values the privately held ion channel specialist at £12.5 million (US$21.9 million). The …See details»
Tonix Pharmaceuticals Holding Corp (TNXP): Tonix …
3 days ago Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights Mon, December 16, 2024 at 5:40 PM GMT+1 • 17 min read ... a …See details»
Ionix Pharmaceuticals - Updates, News, Events, Signals & Triggers
A leader in the discovery and development of new analgesic medicines for the treatment of acute and chronic pain.See details»
Tonix Pharmaceuticals Provides Update on the Development of Its …
Aug 16, 2024 Tonix Pharmaceuticals Holding Corp. World Health Organization (WHO) has declared spread of mpox in multiple African countries a public health emergency of …See details»
Home - Tonix Pharmaceuticals
Nov 26, 2024 About Tonix Pharmaceuticals. Tonix has a robust pipeline of programs in development stages ranging from preclinical to preparing for NDA submission, across multiple …See details»
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial …
2 days ago CHATHAM, N.J., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical …See details»
Ionix Pharmaceuticals - Tech Stack, Apps, Patents & Trademarks
A leader in the discovery and development of new analgesic medicines for the treatment of acute and chronic pain.See details»
Ionix - Crunchbase Company Profile & Funding
Ionix is the maker of Pokemon, Dragon2 and Tenkai Knights brands, games and apps.See details»
Tonix Pharmaceuticals Reports Third Quarter 2024 ... - TradingView
CHATHAM, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. TNXP (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed …See details»